-
A Cost-Minimization and Budget Impact Analysis of NT-proBNP Screening for Systematic Sclerosis-Related Pulmonary Arterial Hypertension in an Australian Healthcare Setting
Sep 9, 2025, 16:22 PM -
Bayesian Network Meta-Analysis of Weight Loss Efficacy for GLP-1 Receptor Agonists and Tirzepatide
Sep 9, 2025, 16:22 PM -
Three Systems, One Market? A Comparative Analysis of Medical Device Reimbursement in Germany, Austria, and Switzerland
Sep 9, 2025, 16:22 PM -
Evaluation of the Societal Impact of Emicizumab in France Since Its Market Authorization: Budget Impact From 2018 to 2024
Sep 9, 2025, 16:22 PM -
Annual Change in Türkiye’s Reimbursement List: A Comparative Descriptive Analysis of the 2023 and 2024 SUT Annex 4-A Lists
Sep 9, 2025, 16:22 PM -
Premature Cancer-Related Morbidity and Mortality in Israel: Years Lived With Disability and Years of Life Lost Productivity Costs
Sep 9, 2025, 16:22 PM -
Generation of Synthetic Patient Data to Overcome Machine Learning Limitations in Healthcare Research: A Systematic Review of Methods, Performance, and Use Cases
Sep 9, 2025, 16:22 PM -
An Analysis of Possible Reference Countries for a US Most-Favored Nation Policy and the Associated Impact on the Global Pharmaceutical Industry
Sep 9, 2025, 16:22 PM -
Budget Impact of an Organized Colorectal Cancer Screening in High-Risk Populations in France
Sep 9, 2025, 16:22 PM -
Advancing a Greener Ecosystem in Health Technology Assessment: A Review of Environmental Integration as an Additional Value Driver
Sep 9, 2025, 16:22 PM -
What Matters Most to Women in Breast Biopsy? A Discrete Choice Experiment in Italy
Sep 9, 2025, 16:22 PM -
Avacopan in the Treatment of ANCA-Associated Vasculitis: A Cost-Utility Analysis in Portugal
Sep 9, 2025, 16:22 PM -
Half-Cycle Correction: It’s Time to Let It Go
Sep 9, 2025, 16:22 PM -
Adoption and Evidence Generation in NICE Early Value Assessments (EVA) for Medtech: Trends Across 2023-2025
Sep 9, 2025, 16:22 PM -
The Impact of Treatment Compliance on Healthcare Resource Utilization Amongst Kidney Transplant Recipients: Results From a Real-World Survey
Sep 9, 2025, 16:22 PM -
Diverging Impacts of Evergreening and Biosimilars on Trastuzumab Utilization and Costs in South Korea: Implications for Sustainable Access and Market Competition
Sep 9, 2025, 16:22 PM -
PACE in Scotland: Utilizing Machine Learning to Assess the Importance of Patient and Clinician Engagement in HTAs in SMC
Sep 9, 2025, 16:22 PM -
Incidence of Treatment-Related Adverse Events From Immune Checkpoint Inhibitors: A Meta-Analysis of Randomized Clinical Trials
Sep 9, 2025, 16:22 PM -
Price Behavior of Originator Adalimumab After Biosimilars Entry: Evidence From the Colombian Market
Sep 9, 2025, 16:22 PM -
Evaluating the Role of Societal Perspectives in the EU Joint Clinical Assessment Framework and in EU-27 Health Technology Assessment Guidelines
Sep 9, 2025, 16:22 PM
